Nordic Pharma Lab ApS: Financial statements 2021
CVR: 39161672
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Nordic Pharma Lab ApS (CVR 39161672) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -106,160 and a net result of DKK -283,024 compared with DKK -20,276 the year before. Equity in the 2021 report amounted to DKK -226,308.
- Gross Profit
- DKK -106,160
- Profit/Loss
- DKK -283,024
- Equity
- DKK -226,308
- Total Assets
- DKK 29,739
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -106 t. | -283 t. | -226 t. | - |
| 2020 | 1 | -41 t. | -20 t. | 57 t. | - |
| 2019 | - | -12 t. | -12 t. | 77 t. | - |
| 2018 | - | -11 t. | -11 t. | 89 t. | - |
Official annual report
Find more companies like Nordic Pharma Lab ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Nordic Pharma Lab ApS has published its annual report for 2020. Revenue came to DKK 1, and the net result was DKK -20,276.
About Nordic Pharma Lab ApS
Nordic Pharma Lab ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2017. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named ApS STM nr. 6145. The management consists of Torsten Bjørn. The company's owners include TT 1919 ApS, Beier Holding ApS and FINANSMANAGEMENT ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -52,093 and a net result of DKK -110,916 compared with DKK -30,573 the year before. Equity in the 2025 report amounted to DKK -429,426.